[go: up one dir, main page]

ES8402273A1 - Un procedimiento para la preparacion de 1,4-dihidropiridinas. - Google Patents

Un procedimiento para la preparacion de 1,4-dihidropiridinas.

Info

Publication number
ES8402273A1
ES8402273A1 ES518489A ES518489A ES8402273A1 ES 8402273 A1 ES8402273 A1 ES 8402273A1 ES 518489 A ES518489 A ES 518489A ES 518489 A ES518489 A ES 518489A ES 8402273 A1 ES8402273 A1 ES 8402273A1
Authority
ES
Spain
Prior art keywords
formula
dihydropyridines
procedure
elevated
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES518489A
Other languages
English (en)
Other versions
ES518489A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES518489A0 publication Critical patent/ES518489A0/es
Publication of ES8402273A1 publication Critical patent/ES8402273A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 1,4-DIHIDROPIRIDINAS Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE Y ES -(CH2)2- O -(CH2)3-; R ES ARILO O HETEROARILO; R ELEVADO 1 Y R ELEVADO 2 SON ALQUILO C1-4 O 2-METOXIETILO; Y R ELEVADO 3 Y R ELEVADO 4 PUEDE SER VARIOS RADICALES. CONSISTE EN LA REACION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN LAS QUE TODOS LOS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE ORGANICO INERTE, TAL COMO UN ALCANOL C1-4, A UNA TEMPERATURA COMPRENDIDA ENTRE 60GC Y 130GC. *FORMULA*. T
ES518489A 1981-03-14 1982-12-22 Un procedimiento para la preparacion de 1,4-dihidropiridinas. Expired ES8402273A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8108088 1981-03-14

Publications (2)

Publication Number Publication Date
ES518489A0 ES518489A0 (es) 1984-01-16
ES8402273A1 true ES8402273A1 (es) 1984-01-16

Family

ID=10520395

Family Applications (2)

Application Number Title Priority Date Filing Date
ES510402A Expired ES8305330A1 (es) 1981-03-14 1982-03-12 Un procedimiento para la preparacion de 1,-4dihidropiridinas.
ES518489A Expired ES8402273A1 (es) 1981-03-14 1982-12-22 Un procedimiento para la preparacion de 1,4-dihidropiridinas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES510402A Expired ES8305330A1 (es) 1981-03-14 1982-03-12 Un procedimiento para la preparacion de 1,-4dihidropiridinas.

Country Status (24)

Country Link
US (1) US4430333A (es)
EP (1) EP0060674B1 (es)
JP (1) JPS57206659A (es)
KR (1) KR860001579B1 (es)
AT (1) ATE15660T1 (es)
AU (1) AU529854B2 (es)
CA (1) CA1205480A (es)
CS (1) CS228917B2 (es)
DD (1) DD202430A5 (es)
DE (1) DE3266272D1 (es)
DK (1) DK155601C (es)
ES (2) ES8305330A1 (es)
FI (1) FI78470C (es)
GR (1) GR75895B (es)
HU (1) HU187657B (es)
IE (1) IE52632B1 (es)
IL (1) IL65222A (es)
NO (1) NO159085C (es)
NZ (1) NZ199990A (es)
PH (1) PH17585A (es)
PL (2) PL131190B1 (es)
PT (1) PT74571B (es)
YU (2) YU42461B (es)
ZA (1) ZA821670B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
EP0094159B1 (en) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives, their production and use
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
HU197881B (en) * 1982-08-06 1989-06-28 Banyu Pharma Co Ltd Process for producing new carbamoyl-oxy-alkyl-carboxy-lic acid derivatives
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
PL140069B1 (en) * 1982-12-21 1987-03-31 Pfizer Method of obtaining new derivatives of dihydropiridine
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US5137889A (en) * 1983-12-02 1992-08-11 Otsuka Pharmaceutical Co., Ltd. Dihydropyridine derivatives and process for preparing the same
EP0168841B1 (en) * 1983-12-19 1988-09-28 Pfizer Limited Dihydropyridine intermediate
GB8401288D0 (en) * 1984-01-18 1984-02-22 Pfizer Ltd Therapeutic agents
US4755512A (en) * 1984-04-11 1988-07-05 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities
US4895846A (en) * 1984-04-11 1990-01-23 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moieties
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
GB8414518D0 (en) * 1984-06-07 1984-07-11 Pfizer Ltd Therapeutic agents
GB8415386D0 (en) * 1984-06-15 1984-07-18 Pfizer Ltd Therapeutic agents
GR851819B (es) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
GB8421039D0 (en) * 1984-08-17 1984-09-19 Wyeth John & Brother Ltd Heterocyclic compounds
US4652573A (en) * 1985-03-14 1987-03-24 Nelson Research & Development Co. Calcium antagonist N-hetero ester 1,4-dihydropyridines
IT1204421B (it) * 1986-06-27 1989-03-01 Boehringer Biochemia Srl 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono
SE465367B (sv) * 1985-08-21 1991-09-02 Glaxo Spa Heterocykliska foereningar och deras framstaellning och farmaceutiska formuleringar
DE3675747D1 (de) * 1985-08-21 1991-01-03 Glaxo Spa 1,4-dihydropyridinverbindungen und ihre herstellung und pharmazeutische formulierung.
DE3531498A1 (de) * 1985-09-04 1987-03-05 Bayer Ag Dihydropyridin-2-hydroxyamine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
FR2602231B1 (fr) * 1986-08-04 1988-10-28 Adir Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
AU7810087A (en) * 1986-08-14 1988-03-08 Byk Gulden Lomberg Chemische Fabrik Gmbh New piperidines
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 １，４−ジヒドロピリジン誘導体
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
IT1205114B (it) * 1987-05-29 1989-03-15 Boehringer Biochemia Srl 2-selenometil-1,4-diidropiridine,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
US4978533A (en) * 1988-11-01 1990-12-18 Pharmaconsult, Inc. Liquid nifidipine composition
US5635503A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Company Dihydropyridine npy antagonists: piperazine derivatives
ES2151850B1 (es) * 1998-10-26 2001-08-16 Esteve Quimica Sa Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
IL156692A0 (en) * 2000-12-29 2004-01-04 Pfizer Ltd Process for making amlodipine maleate
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
WO2016155815A1 (en) 2015-04-01 2016-10-06 Ceva Sante Animale Oral solid dosage form of amlodipine and veterinary uses thereof
KR102719122B1 (ko) * 2019-06-19 2024-10-17 현대자동차주식회사 차량의 통합열관리모듈

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248150A1 (de) 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3946027A (en) 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 3,5,6-Tricarboxy-4-pyridyl-1,4-dihydropyridine derivatives
US3946028A (en) 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 2,3,5,6-Tetracarboxy-4-pyridyl-1,4-dihydropyridine derivatives
US3943140A (en) 1972-09-30 1976-03-09 Bayer Aktiengesellschaft 2,3,5,6-Tetracarboxy-1,4-dihydropyridine derivatives
BE843576A (fr) 1975-04-03 1976-12-29 Derives de 1,4-dihydropyridine et leur procede de preparation
GB1552911A (en) 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2658183A1 (de) 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2715182A1 (de) 1977-04-05 1978-10-19 Bayer Ag 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4177278A (en) 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
US4307103A (en) 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
KR830009025A (ko) 1983-12-17
ES510402A0 (es) 1983-04-01
FI820840L (fi) 1982-09-15
AU8136482A (en) 1982-11-04
ES518489A0 (es) 1984-01-16
ZA821670B (en) 1983-01-26
NO159085B (no) 1988-08-22
PL131190B1 (en) 1984-10-31
PH17585A (en) 1984-10-02
NZ199990A (en) 1984-07-06
AU529854B2 (en) 1983-06-23
PL235363A1 (en) 1983-03-14
IL65222A (en) 1985-08-30
EP0060674B1 (en) 1985-09-18
PL238960A1 (en) 1983-07-18
YU42902B (en) 1988-12-31
YU155884A (en) 1985-03-20
YU42461B (en) 1988-08-31
JPS57206659A (en) 1982-12-18
KR860001579B1 (ko) 1986-10-10
DE3266272D1 (en) 1985-10-24
HU187657B (en) 1986-02-28
YU55082A (en) 1984-12-31
DD202430A5 (de) 1983-09-14
US4430333A (en) 1984-02-07
PL132199B1 (en) 1985-02-28
EP0060674A1 (en) 1982-09-22
ATE15660T1 (de) 1985-10-15
IE52632B1 (en) 1988-01-06
NO159085C (no) 1988-11-30
IE820572L (en) 1982-09-14
JPS6155907B2 (es) 1986-11-29
GR75895B (es) 1984-08-02
ES8305330A1 (es) 1983-04-01
FI78470B (fi) 1989-04-28
FI78470C (fi) 1989-08-10
PT74571B (en) 1984-11-27
DK155601B (da) 1989-04-24
DK155601C (da) 1989-09-11
DK109982A (da) 1982-09-15
IL65222A0 (en) 1982-05-31
PT74571A (en) 1982-04-01
CA1205480A (en) 1986-06-03
CS228917B2 (en) 1984-05-14
NO820825L (no) 1982-09-15

Similar Documents

Publication Publication Date Title
ES8402273A1 (es) Un procedimiento para la preparacion de 1,4-dihidropiridinas.
ES8204428A1 (es) Procedimiento para preparar alfa-aril-1h-1,2,4-triazol-1- etanoles
ES8306121A1 (es) Procedimiento para la obtencion de derivados de imidazol trisustituidos.
ES8402306A1 (es) Un procedimiento para la preparacion de nuevos derivados de oxabicicloalcano.
ES8404184A1 (es) Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
ES8400415A1 (es) "un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina".
ES8506616A1 (es) Un procedimiento para la preparacion de carboxamidas
ES8305681A1 (es) Procedimiento para la obtencion de fenileteres sustituidos.
ES8306750A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
ES8303426A1 (es) Un procedimiento para la preparacion de un compuesto de cefalosporina.
ES8300692A1 (es) Un procedimiento para la preparacion de derivados de acido carbamico
ES8301990A1 (es) Un procedimiento para la preparacion de acidos 1, carbadestiapen-2-em-3-carboxililos 2- y 6- sustituidos.
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8300677A1 (es) Un procedimiento para preparar compuestos de aminoetanol
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8201116A1 (es) Procedimiento para preparar derivados de 2-nitro-5-(fenoxi sustituido)-benzoilo
ES8305355A1 (es) Un procedimiento para la preparacion de derivados del indol.
ES8404317A1 (es) Metodo de preparar aminoaminoacidos y analogos.
ES8603400A1 (es) Derivados de prostaglandina
ES8607982A1 (es) Un procedimiento para preparar un derivado de uridina
ES8609246A1 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES8800193A1 (es) Procedimiento para preparar 2,4-difenil-1,3-dioxanos
ES8606321A1 (es) Un procedimiento para preparar un derivado de 2-hidroxi-3- (4-fenilpiperazimil)propoxi-benzofurano